Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells

Molecular Carcinogenesis

Volumn 21, Issue 4, 1998, Pages 261-272

  Biscardi, Jacqueline S ^a   Belsches, Allison P ^a   Parsons, Sarah J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Breast cancer; c Src; HER1; Tumorigenesis

Indexed keywords

GAMMA UROGASTRONE; PROTEIN KINASE;

ARTICLE; BREAST TUMOR; CANCER DIAGNOSIS; CANCER STAGING; CARCINOGENESIS; EARLY DIAGNOSIS; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DISEASE PROGRESSION; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MACROMOLECULAR SUBSTANCES; MICE; MICE, INBRED C3H; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

MURINAE; MUS MUSCULUS;

EID: 0031979414     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N     Document Type: Article

References (48)

1. Sainsbury JRC, Malcolm AJ, Appleton DR, Farndon JR, Harris AL. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 38:1225-1228, 1985.
2. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1:1398-1402, 1987.
3. Hendler FJ, Ozanne BW. Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest 74:647-651, 1984.
4. Hunts J, Ueda M, Ozawa S, Abe O, Pastan I, Shimizu N. Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas. Japanese J Cancer Res 76:663-666, 1985.
5. Khazaei K, Schirrmacher V, Lichtner R. EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 12:255-274, 1983.
6. Libermann TA, Nussbaum HR, Razon N, et al. Amplification and overexpression of the EGF receptor gene in primary human glioblastomas. Nature 313:144-147, 1985.
7. Singletary SE, Baker FL, Spitzer G, et al. Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res 47;403-406, 1987.
8. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212, 1990.
9. Harris JR, Lippmann ME, Veronesi U, Willett W. Breast cancer (2). N Engl J Med 327:473-480, 1992.
10. Koenders PG, Beex LVAM, Geurts-Moespot A, Heuvel JJTM, Kienhuis CBM, Benraad TJ. Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. Cancer Res 51:4544-4548, 1991.
11. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182, 1986.
12. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/ neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712, 1989.
13. Toi M, Osaki A, Yamada H, Toge T. Epidermal growth factor receptor expression as a prognostic indicator in breast cancer. Eur J Cancer 27:977-980, 1991.
14. De Potter CR, Beghin C, Makar AP, Vandekerckhove D, Roels HJ. The neu-oncogene protein as a predictive factor for haematogenous metastasis in breast cancer patients. Int J Cancer 45:55-58, 1990.
15. Gusterson BA, Machin LG, Gullick WJ, et al. c-erbB-2 expression in benign and malignant breast cancer. Br J Cancer 58:453-457, 1988.
16. Gusterson BA, Machin LG, Gullick WJ, et al. Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer. Int J Cancer 42:842-845, 1988.
17. Maguire HC Jr, Hellman ME, Greene MI, Yeh I. Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast. Pathobiology 60:117-121, 1992.
18. Ramachandra S, Machin L, Ashley S, Monaghan P, Gusterson BA. Immunohistochemical detection of c-erbB-2 in in situ breast carcinoma - a detailed morphological analysis. J Pathol 161:7-14, 1990.
19. van de Vijver MJ, Peterse JL, Mooi WJ, et al. neu-protein overexpression in breast cancer. N Engl J Med 319:1239-1245, 1988.
20. Battaglia F, Scambia G, Rossi S, et al. Epidermal growth factor receptor in human breast cancer: Correlation with steroid hormone receptors and axillary lymph node involvement. Eur J Cancer Clin Oncol 24:1685-1690, 1988.
21. Kaufmann AM, Lichtner RB, Schirrmacher V, Khazaie K. Indication of apoptosis by EGF receptor in rat mammary adenocarcinoma cells coincides with enhanced spontaneous tumor metastasis. Oncogene 13:2349-2358, 1996.
22. Lichtner R, Kauffmann AM, Kittmann A, et al. Ligand mediated activation of ectopic EGF receptor promotes matrix protein adhesion and lung colonization of rat mammary adenocarcinoma cells. Oncogene 10:1823-1832, 1995.
23. Velu TJ, Beguinot L, Vass WC, et al. Epidermal growth factor-dependent transformation by a human EGF receptor protooncogene. Science 238:1408-1410, 1987.
24. c-src activation in human colon carcinoma. J Clin Invest 3:2025-2033, 1989.
25. c-src protein kinase in adult and fetal human tissue: High activities in some sarcomas and mammary carcinomas. Cancer Res 43:1696-1702, 1983.
26. Ottenhalff-Kalff AE, Rijksen G, van Beurden EACM, Hennipman A, Michels AA, Staal GEJ. Characterization of protein tyrosine kinases from human breast cancer: Involvement of the c-src oncogene product. Cancer Res 52:4773-4778, 1992.
27. c-src protein kinase activity in human tumor cell lines and tissues. J Biol Chem 261:13754-13759, 1986.
28. c-src. Mol Cell Biol 8:497-501, 1988.
29. c-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-Src. Mol Cell Biol 9:1536-1544, 1989.
30. Roche S, Koegl M, Barone MV, Roussel MF, Courtneidge SA. DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases. Mol Cell Biol 15:1102-1109, 1995.
31. c-src with two major signaling pathways in human breast cancer. Proc Natl Acad Sci USA 91:83-87, 1994.
32. Muthuswamy SK, Muller WJ. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Oncogene 11:271-279, 1995.
33. Stover DR, Becker M, Leibetanz J, Lydon NB. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85α. J Biol Chem 270:15591-15597, 1995.
34. Maa M-C, Leu T-H, McCarley DJ, Schatzman RC, Parsons SJ. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: Implications for the etiology of multiple human cancers. Proc Natl Acad Sci USA 92:6981-6985, 1995.
35. Pelicci G, Lanfrancona L, Grignani F, et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104, 1992.
36. Rhee SG. Inositol phospholipids-specific phospholipase C: Interaction of the γ1 isoform with tyrosine kinase. Trends Biochem Sci 16:297-301, 1991.
37. Ruff-Jamison S, McGlade J, Pawson T, Chen K, Cohen S. Epidermal growth factor stimulates the tyrosine phosphorylation of SHC in the mouse. J Biol Chem 268:7610-7612, 1993.
38. Katagiri T, Ting JP, Dy R, Prokop C, Cohen P, Earp HS. Tyrosine phosphorylation of a c-Src-like protein is increased in membranes of CD4-CD8-T lymphocytes from lpr/lpr mice. Mol Cell Biol 9:4914-4922, 1989.
39. c-src tyrosine kinase activity during secretion in stimulated bovine adrenal chromaffin cells. J Neurosci Res 24:38-48, 1989.
40. src of avian and mammalian origin. J Virol 51:701-705, 1984.
41. Parsons SJ, McCarley DJ, Raymond VW, Parsons JT. Localization of conserved and nonconserved epitopes within the Rous sarcoma virus-encoded Src protein. J Virol 59:755-758, 1986.
42. Reuter C, Catling A, Weber MJ. Immune complex kinase assays for mitogen-activated protein kinase and MEK. Methods Enzymol 255:245-256, 1995.
43. c-src. Cell 49:75-82, 1987.
44. Sato K-I, Sato A, Aoto M, Fukami Y. c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochem Biophys Res Commun 210:844-851, 1995.
45. Osherov N, Levitzki A. Epidermal-growth-factor-dependent activation of the Src-family kinases. Eur J Biochem 225:1047-1053, 1994.
46. Oude Weernink PA, Ottenhalff-Kalff AE, Vendrig MP, van Beurden EACM, Staal GEJ, Rijksen G. Functional interaction between the epidermal growth factor receptor and c-Src kinase activity. FEBS Lett 352:296-300, 1994.
47. Campbell DH, deFazio A, Sutherland RL, Daly RJ. Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines. Int J Cancer 68:485-492, 1996.
48. Cooper JA, Howell B. The when and how of Src regulation. Cell 73:1051-1054, 1993.